Alzheimer’s Research UK (ARUK) has reiterated its call for a Dementia Medicines Taskforce as part of the government’s forthcoming 10-year dementia strategy. ARUK says the taskforce would act as a “necessary catalyst” for the development of dementia treatments, especially given historic under-investment in dementia research and the government’s failure so far to honour its “dementia moonshot” promise to double funding for research.
